These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 9771081)
21. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost. Tamer C; Oksüz H Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574 [TBL] [Abstract][Full Text] [Related]
22. The usefulness of dapiprazole, an alpha-adrenergic blocking agent, in pigmentary glaucoma. Mastropasqua L; Carpineto P; Ciancaglini M; Gallenga PE Ophthalmic Surg Lasers; 1996 Sep; 27(9):806-9. PubMed ID: 8878205 [TBL] [Abstract][Full Text] [Related]
23. Ocular tension and pupil diameter effects of timolol 0.50% and pilocarpine 2% or 4% in association. Taverniti L; Voccia L; Amoroso L; De Stefano C; Virno M Acta Ophthalmol Scand Suppl; 1997; (224):55-6. PubMed ID: 9589741 [No Abstract] [Full Text] [Related]
24. [Efficacy and safety of timoptic depot in hypotensive therapy of glaucoma]. Erichev VP; Iakubova LV Vestn Oftalmol; 1998; 114(1):8-9. PubMed ID: 9584629 [TBL] [Abstract][Full Text] [Related]
25. A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patients. Manni G; Centofanti M; Parravano M; Oddone F; Bucci MG Graefes Arch Clin Exp Ophthalmol; 2004 Sep; 242(9):767-70. PubMed ID: 15241611 [TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure. Shin DH; Feldman RM; Sheu WP; Ophthalmology; 2004 Feb; 111(2):276-82. PubMed ID: 15019375 [TBL] [Abstract][Full Text] [Related]
27. Sympathetic use of latanoprost 0.005% in 30 eyes. Montrone F; Macinagrossa G; Tenerelli F Acta Ophthalmol Scand Suppl; 1998; (227):38-9. PubMed ID: 9972340 [TBL] [Abstract][Full Text] [Related]
28. Ocular hypotensive effects and safety over 3 months of switching from an unfixed combination to latanoprost 0.005%/timolol maleate 0.5% fixed combination. Inoue K; Okayama R; Higa R; Sawada H; Wakakura M; Tomita G J Ocul Pharmacol Ther; 2011 Dec; 27(6):581-7. PubMed ID: 22011049 [TBL] [Abstract][Full Text] [Related]
29. Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The APOLLO Study. Weinreb RN; Scassellati Sforzolini B; Vittitow J; Liebmann J Ophthalmology; 2016 May; 123(5):965-73. PubMed ID: 26875002 [TBL] [Abstract][Full Text] [Related]
30. Timolol-pilocarpine combined vs timolol and pilocarpine given separately. Söderström MB; Wallin O; Granström PA; Thorburn W Am J Ophthalmol; 1989 May; 107(5):465-70. PubMed ID: 2653044 [TBL] [Abstract][Full Text] [Related]
31. Combined timolol and pilocarpine vs pilocarpine alone and timolol alone in the treatment of glaucoma. Zadok D; Geyer O; Zadok J; Lazar M; Krakowski D; Nemet P Am J Ophthalmol; 1994 Jun; 117(6):728-31. PubMed ID: 8198156 [TBL] [Abstract][Full Text] [Related]
32. [Proxodolol, a new domestic preparation for lowering intraocular pressure in glaucoma]. Ermakova VN; Iuzhakov SD; Mashkovskiĭ MD; Kolomoĭtseva EM Vestn Oftalmol; 1995; 111(2):4-7. PubMed ID: 7645180 [TBL] [Abstract][Full Text] [Related]
33. A prospective, long-term, randomized study of the efficacy and safety of the drug combination pilocarpine 1% with clonidine 0.06% or clonidine 0.125% versus timolol 0.25%. Sihota R; Rajashekhar YL; Venkatesh P; Agarwal H J Ocul Pharmacol Ther; 2002 Dec; 18(6):499-506. PubMed ID: 12537676 [TBL] [Abstract][Full Text] [Related]
34. Effectiveness and safety of switching from prostaglandin analog monotherapy to prostaglandin/timolol fixed combination therapy or adding ripasudil. Inoue K; Ishida K; Tomita G Jpn J Ophthalmol; 2018 Jul; 62(4):508-516. PubMed ID: 29797109 [TBL] [Abstract][Full Text] [Related]
35. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines. Stewart WC; Konstas AG; Nelson LA; Kruft B Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886 [TBL] [Abstract][Full Text] [Related]
36. [Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients]. Kałuzny JJ; Szaflik J; Czechowicz-Janicka K; Kałuzny J; Orzałkiewicz A; Zaleska-Zmijewska A; Krajewska M; Stewart JA; Leech JN; Stewart WC Klin Oczna; 2004; 106(1-2 Suppl):241-2. PubMed ID: 15510513 [TBL] [Abstract][Full Text] [Related]
37. Timolol maleate 0.5% versus timolol maleate in gel forming solution 0.5% (Timolol GFS) in open angle glaucoma in India. Preliminary safety and efficacy study. Kumar H; Sudan R; Sethi HS; Sony P Indian J Ophthalmol; 2002 Mar; 50(1):21-3. PubMed ID: 12090082 [TBL] [Abstract][Full Text] [Related]
38. A double-masked study of timolol and pilocarpine combined. Airaksinen PJ; Valkonen R; Stenborg T; Takki K; Klemetti A; Kontkanen M; Oskala P Am J Ophthalmol; 1987 Dec; 104(6):587-90. PubMed ID: 3318475 [TBL] [Abstract][Full Text] [Related]
39. [Primary open-angle glaucoma. Effects of an eyedrop combining timolol and pilocarpine on the ocular pressure]. Leroy C; Collignon-Brach J J Fr Ophtalmol; 1990; 13(1-2):29-32. PubMed ID: 2212504 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of multiple doses of 4 and 6% timolol, and timolol combined with 2% pilocarpine in clinically normal beagles and beagles with glaucoma. Gelatt KN; Larocca RD; Gelatt JK; Strubbe DT; MacKay EO Am J Vet Res; 1995 Oct; 56(10):1325-31. PubMed ID: 8928950 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]